Dear Sirs, we are pleased to share with you an article published on BILAN, the main economic magazine in Romandy (the French-speaking part of western Switzerland), regarding the assistance services evolution toward the Enterprises, where Financial Technologies represents an international excellence and one of the main dynamic actors and, as reported in the title, at [...]
On 22, 23 and 24 September 2016, ECEC China Europe M&A Summit (EUROPE CHINESE ENTREPRENEURS CONVENTION) took place in Campione d’Italia, with the support and organization of Italy-China Foundation and the City Authorities. A huge number of economic exponents and Chinese Entrepreneurs resident in all Countries of the European Union attended the event, that will [...]
Dear Ladies and Gentlemen, With great pleasure, we are pleased to share with you an article published yesterday on CHINA DAILY about the transaction realized between Altergon-Technogenetics with the Chinese giant KHB, one of China’s most important pharmaceutical groups. This transaction was entirely overviewed on behalf of the European Parties, by Financial Technologies also for [...]
With great pleasure, we inform you that, a few days from the start of operations by Financial Technologies Geneva SA, Financial Technologies has obtained the international Quality Certification ISO 9001 Standard 2015 on its management and operating processes. This Certification has been conferred by the Swiss Association for Quality and Management Systems (SQS).
With great pleasure we inform you that Financial Technologies SA (FT) has established another new daughter Company, Financial Technologies Geneva SA (FTG), to better respond to the Advisory requests from international Entrepreneurial Clients. Such new operational unit represents a further step in consolidating the Group presence in Switzerland in the perspective of overseas Strategic Transactions.
Corporate support service of Financial Technologies, in economic development activities in China, rendered to the City of Lugano.
We are pleased to announce the closing of the sale of the total stake of italian enterprise Technogenetics Srl in Lodi, previously controlled by Bouty SpA (this latter controlled by the Swiss group IBSA) to the Chinese group Shanghai Kehua Bio-engineering KHB Co. Ltd.